Ganesh Benzoplast Share Price
Sector: Chemical Manufacturing
107.35 -1.45 (-1.33%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
103.70
Today’s High
109.35
52 Week Low
100.70
52 Week High
179.90
107.60 -1.21 (-1.11%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
102.70
Today’s High
108.24
52 Week Low
100.92
52 Week High
180
Key Metrics
- Market Cap (In Cr) 773.1
- Beta 0.73
- Div. Yield (%) 0
- P/B 1.46
- TTM P/E 19.77
- Peg Ratio 67.64
- Sector P/E 17.01
- D/E 0
- Open Price 109.35
- Prev Close 108.8
Ganesh Benzoplast Analysis
Price Analysis
-
1 Week-9.22%
-
3 Months-6.22%
-
6 Month-15.87%
-
YTD-17.85%
-
1 Year-29.89%
Risk Meter
- 60% Low risk
- 60% Moderate risk
- 60% Balanced Risk
- 60% High risk
- 60% Extreme risk
Ganesh Benzoplast News
Ganesh Benzoplast Limited Allotted Additional Land for 25 years at JNPT
3 min read . 07 Jul 2022Ganesh Benzoplast Ltd ventures into production of Ethanol and ENA in Nasik
2 min read . 11 Mar 2022Ganesh Benzoplast Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2025
- Total Revenue
- 374.31
- Selling/ General/ Admin Expenses Total
- 29.48
- Depreciation/ Amortization
- 22.38
- Other Operating Expenses Total
- 130.57
- Total Operating Expense
- 333.14
- Operating Income
- 41.18
- Net Income Before Taxes
- 51.92
- Net Income
- 38.09
- Diluted Normalized EPS
- 9.85
- Period
- 2025
- Total Assets
- 723.51
- Total Liabilities
- 185.17
- Total Equity
- 538.34
- Tangible Book Valueper Share Common Eq
- 71.65
- Period
- 2025
- Cashfrom Operating Activities
- 54.94
- Cashfrom Investing Activities
- -60.14
- Cashfrom Financing Activities
- -0.88
- Net Changein Cash
- -6.08
- Period
- 2024
- Total Revenue
- 477.08
- Selling/ General/ Admin Expenses Total
- 111.91
- Depreciation/ Amortization
- 20.26
- Total Operating Expense
- 401.76
- Operating Income
- 75.32
- Net Income Before Taxes
- 83.99
- Net Income
- 61.44
- Diluted Normalized EPS
- 9.07
- Period
- 2024
- Total Assets
- 676.61
- Total Liabilities
- 175
- Total Equity
- 501.62
- Tangible Book Valueper Share Common Eq
- 66.55
- Period
- 2024
- Cashfrom Operating Activities
- 83.28
- Cashfrom Investing Activities
- -146.73
- Cashfrom Financing Activities
- 72.95
- Net Changein Cash
- 9.5
- Period
- 2023
- Total Revenue
- 420.85
- Selling/ General/ Admin Expenses Total
- 78.32
- Depreciation/ Amortization
- 17.28
- Total Operating Expense
- 350.79
- Operating Income
- 70.06
- Net Income Before Taxes
- 74.23
- Net Income
- 55.08
- Diluted Normalized EPS
- 8.61
- Period
- 2023
- Total Assets
- 533.35
- Total Liabilities
- 176.5
- Total Equity
- 356.85
- Tangible Book Valueper Share Common Eq
- 51.29
- Period
- 2023
- Cashfrom Operating Activities
- 40.61
- Cashfrom Investing Activities
- -62.14
- Cashfrom Financing Activities
- 14.99
- Net Changein Cash
- -6.54
- Period
- 2022
- Total Revenue
- 357.51
- Selling/ General/ Admin Expenses Total
- 89.6
- Depreciation/ Amortization
- 14.66
- Total Operating Expense
- 311.68
- Operating Income
- 45.83
- Net Income Before Taxes
- 45.16
- Net Income
- 32.69
- Diluted Normalized EPS
- 5.34
- Period
- 2022
- Total Assets
- 397.56
- Total Liabilities
- 117.05
- Total Equity
- 280.52
- Tangible Book Valueper Share Common Eq
- 41.38
- Period
- 2022
- Cashfrom Operating Activities
- 86.19
- Cashfrom Investing Activities
- -59.05
- Cashfrom Financing Activities
- -25.48
- Net Changein Cash
- 1.66
- Period
- 2021
- Total Revenue
- 270.41
- Selling/ General/ Admin Expenses Total
- 48.82
- Depreciation/ Amortization
- 14.98
- Total Operating Expense
- 211.72
- Operating Income
- 58.69
- Net Income Before Taxes
- 53.38
- Net Income
- 21.88
- Diluted Normalized EPS
- 4.35
- Period
- 2021
- Total Assets
- 377.97
- Total Liabilities
- 145.57
- Total Equity
- 232.4
- Tangible Book Valueper Share Common Eq
- 33.66
- Period
- 2021
- Cashfrom Operating Activities
- 61.56
- Cashfrom Investing Activities
- -32.52
- Cashfrom Financing Activities
- -21.95
- Net Changein Cash
- 7.1
- Period
- 2020
- Total Revenue
- 246.67
- Selling/ General/ Admin Expenses Total
- 51.74
- Depreciation/ Amortization
- 12.97
- Total Operating Expense
- 203.97
- Operating Income
- 42.71
- Net Income Before Taxes
- 33.66
- Net Income
- 33.66
- Diluted Normalized EPS
- 7.94
- Period
- 2020
- Total Assets
- 270.56
- Total Liabilities
- 125.03
- Total Equity
- 145.53
- Tangible Book Valueper Share Common Eq
- 28.11
- Period
- 2020
- Cashfrom Operating Activities
- 26.51
- Cashfrom Investing Activities
- -12.75
- Cashfrom Financing Activities
- -13.72
- Net Changein Cash
- 0.04
- Period
- 2019
- Total Revenue
- 211.64
- Selling/ General/ Admin Expenses Total
- 33.01
- Depreciation/ Amortization
- 12.39
- Total Operating Expense
- 167.22
- Operating Income
- 44.42
- Net Income Before Taxes
- 31.27
- Net Income
- 31.27
- Diluted Normalized EPS
- 7.39
- Period
- 2019
- Total Assets
- 251.01
- Total Liabilities
- 139.03
- Total Equity
- 111.98
- Tangible Book Valueper Share Common Eq
- 21.63
- Period
- 2019
- Cashfrom Operating Activities
- 60.65
- Cashfrom Investing Activities
- -27.58
- Cashfrom Financing Activities
- -30.23
- Net Changein Cash
- 2.85
- Period
- 2025-03-31
- Total Revenue
- 99.93
- Selling/ General/ Admin Expenses Total
- 8.24
- Depreciation/ Amortization
- 5.73
- Other Operating Expenses Total
- 40.19
- Total Operating Expense
- 118.79
- Operating Income
- -18.86
- Net Income Before Taxes
- -16.15
- Net Income
- -13.19
- Diluted Normalized EPS
- 2.2
- Period
- 2025-03-31
- Total Assets
- 723.51
- Total Liabilities
- 185.17
- Total Equity
- 538.34
- Tangible Book Valueper Share Common Eq
- 71.65
- Period
- 2025-03-31
- Cashfrom Operating Activities
- 54.94
- Cashfrom Investing Activities
- -60.14
- Cashfrom Financing Activities
- -0.88
- Net Changein Cash
- -6.08
- Period
- 2024-12-31
- Total Revenue
- 89.22
- Selling/ General/ Admin Expenses Total
- 7.65
- Depreciation/ Amortization
- 5.59
- Other Operating Expenses Total
- 31.53
- Total Operating Expense
- 67.82
- Operating Income
- 21.41
- Net Income Before Taxes
- 24.24
- Net Income
- 18.39
- Diluted Normalized EPS
- 2.55
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 97.63
- Selling/ General/ Admin Expenses Total
- 6.81
- Depreciation/ Amortization
- 5.56
- Other Operating Expenses Total
- 34.19
- Total Operating Expense
- 78.64
- Operating Income
- 18.98
- Net Income Before Taxes
- 21.84
- Net Income
- 16.46
- Diluted Normalized EPS
- 2.29
- Period
- 2024-09-30
- Total Assets
- 702.87
- Total Liabilities
- 168.6
- Total Equity
- 534.27
- Tangible Book Valueper Share Common Eq
- 71.09
- Period
- 2024-09-30
- Cashfrom Operating Activities
- 23.09
- Cashfrom Investing Activities
- -32.77
- Cashfrom Financing Activities
- 0.01
- Net Changein Cash
- -9.68
- Period
- 2024-06-30
- Total Revenue
- 87.53
- Selling/ General/ Admin Expenses Total
- 6.79
- Depreciation/ Amortization
- 5.5
- Other Operating Expenses Total
- 24.66
- Total Operating Expense
- 67.88
- Operating Income
- 19.65
- Net Income Before Taxes
- 21.99
- Net Income
- 16.43
- Diluted Normalized EPS
- 2.28
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 146.26
- Selling/ General/ Admin Expenses Total
- 7.26
- Depreciation/ Amortization
- 5.79
- Other Operating Expenses Total
- 39.22
- Total Operating Expense
- 130.94
- Operating Income
- 15.32
- Net Income Before Taxes
- 20.9
- Net Income
- 14.29
- Diluted Normalized EPS
- 2.04
- Period
- 2024-03-31
- Total Assets
- 676.61
- Total Liabilities
- 175
- Total Equity
- 501.62
- Tangible Book Valueper Share Common Eq
- 66.55
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 83.28
- Cashfrom Investing Activities
- -146.73
- Cashfrom Financing Activities
- 72.95
- Net Changein Cash
- 9.5
- Period
- 2023-12-31
- Total Revenue
- 106.2
- Selling/ General/ Admin Expenses Total
- 6.58
- Depreciation/ Amortization
- 5.11
- Other Operating Expenses Total
- 34.08
- Total Operating Expense
- 87.21
- Operating Income
- 18.99
- Net Income Before Taxes
- 20.8
- Net Income
- 16.08
- Diluted Normalized EPS
- 2.34
- Period
- 2023-12-31
- Period
- 2023-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Ganesh Benzoplast Technical
Moving Average
SMA
- 5 Day125.66
- 10 Day119.62
- 20 Day120.11
- 50 Day117.65
- 100 Day122.86
- 300 Day136.87
Ganesh Benzoplast Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Bodal Chemicals
- 73.61
- -1.2
- -1.6
- 88
- 49.6
- 924.98
- Shivalik Rasayan
- 580.9
- -3.85
- -0.66
- 873.6
- 500.5
- 903.45
- Ganesh Benzoplast
- 107.35
- -1.45
- -1.33
- 179.9
- 100.7
- 773.1
- Zuari Agro Chemicals
- 211.75
- -1.05
- -0.49
- 268
- 151
- 890.58
- Transpek Industry
- 1570
- -10.95
- -0.69
- 1896
- 1100.05
- 880.34
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Bodal Chemicals
- 1248.2
- 0.87
- 5.32
- 3.37
- Shivalik Rasayan
- 71.16
- 2.21
- 7.08
- 11.66
- Ganesh Benzoplast
- 13.04
- 1.72
- 12.21
- 11.01
- Zuari Agro Chemicals
- 5.53
- 0.49
- 18.23
- 5.98
- Transpek Industry
- 18.08
- 1.19
- 9.73
- 8.66
Ganesh Benzoplast Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 14-May-25
- Audited Results
- 12-Feb-25
- Quarterly Results
- 14-Nov-24
- Quarterly Results
- 12-Aug-24
- Quarterly Results & A.G.M.
- 30-May-24
- Audited Results
- 12-Feb-24
- Quarterly Results
- 29-Jan-24
- Others
- 05-Dec-23
- Others
- 07-Nov-23
- Quarterly Results
- 11-Aug-23
- Quarterly Results
- Meeting Date
- Announced on
- Purpose
- 25-Sept-24
- 06-Sept-24
- AGM
- 22-Feb-24
- 29-Jan-24
- EGM
- 28-Dec-23
- 06-Dec-23
- EGM
- 29-Sept-23
- 05-Sept-23
- AGM
- 21-Jul-23
- 19-Jun-23
- POM
- 27-Sept-22
- 30-Aug-22
- AGM
- 05-Mar-22
- 01-Feb-22
- POM



